Results 91 to 100 of about 2,131 (185)

Fremanezumab for migraine in children and adolescents: A promising option for Pakistan

Journal of the Pakistan Medical Association
Dear Madam, In Pakistan, migraine affects an estimated 22.5% of the population, which is notably higher than the global annual prevalence of 15%.
Hadia Ahsan
doaj   +1 more source

Anti-CGRP monoclonal antibodies in migraine prevention: a systematic review

Headache Medicine
Introduction Migraine is a disabling neurological condition with a significant impact on quality of life. Preventive treatment is essential for patients with frequent attacks or greater disability, although traditional therapies may be limited by ...
Leonardo Lima Porto Araujo, Renan Guedes de Brito, Bruna Correia Sarno, Ádila Fernanda Pereira Martins, Luis Filipe de Jesus Teles, Luiz Felipe Fernandes Caldas, Karine Viana Andrade Cunha, Mariana Barreto de Oliveira Dias, Beatriz Lima Dantas   +8 more
doaj   +2 more sources

Efficacy of fremanezumab in patients with migraine and comorbid depression: a systematic review and meta-analysis

Headache Medicine
Introduction Migraine is the leading cause of disability among individuals under 50 years of age. Population-based studies indicate that depression is a common comorbidity in individuals living with migraine, with a bidirectional relationship in which ...
Carolina Alves Corrêa, Gabriela Carolino, Yasmin Nunes, Amanda Rabelo, John Neto, Julia Oliveira   +5 more
doaj   +2 more sources

Physical activity as a predictor of fremanezumab response in chronic migraine – the Phy-Fre-Mig study

The Journal of Headache and Pain
Background The relationship between physical activity (PA) and migraine is insufficiently understood. Studies have not analysed levels of PA or Time Sitting (TS) during preventive treatment, nor the role these might play in the response to preventive ...
Álvaro Sierra-Mencía, Andrea Recio-García, David García-Azorín, Antonio José Molina de la Torre, Isabel Ros González, Ángel Luis Guerrero-Peral   +5 more
doaj   +1 more source

Treatment of migraine with fremanezumab and sleep: A preliminary case series

Cephalalgia Reports
Background Migraine is a prevalent neurological disease that has socioeconomic and functional impact. It is also frequently associated with sleep disorders.
Agustin Melo-Carrillo, Joaquin Gorrissen, Amanda Macone, Rami Burstein, Sait Ashina   +4 more
doaj   +1 more source

Fremanezumab for migraine in clinical practice: a systematic review and meta-analysis

Introduction: Although the efficacy of fremanezumab in treating migraine has been proven in randomized controlled trials, its effectiveness is not well understood.
Pascual Morena, Carlos, Martínez García, Irene, Flor García, Amparo, Cavero Redondo, Iván, del Saz Lara, Alicia, Lever Megina, Carla Geovanna, Fernández Bravo-Rodrigo, Jaime, Patiño Cardona, Silvana   +7 more
core   +1 more source

Current Evidence on the Use of Calcitonin Gene-Related Peptide-Targeting Therapies in Children and Adolescents. [PDF]

Curr Pain Headache Rep
Shin L, Moon R, Gelfand A.
europepmc   +1 more source

Hair loss in the era of CGRP inhibition: emerging evidence, mechanisms, and clinical implications. [PDF]

Front Neurol
Antanaitytė A, Jokubaitis M, Jokubaitė J, Ryliškienė K.   +3 more
europepmc   +1 more source

Anti-CGRP Monoclonal Antibodies in Chronic Migraine: A Position Statement of the Brazilian Academy of Headache and Orofacial Pain. [PDF]

Cureus
Krymchantowski A, Júnior HMDS, Silva-Néto RP, Jevoux C, Costa ALC, Bordini CA, De Vasconcelos CAC, Goncalves DG, Grossi D, Piovesan É, Dach F, Rezende Filho F, Pereira Júnior F, Fortini I, Barbosa J, Marquez JO, Stechman Neto J, Stuginski Barbosa J, Bruscky I, Pinto Vidor L, Silva Lopes L, Queiroz LP, Bigal M, Arruda MA, Bruno M, Silva MT, Pimentel MLV, Beiral Hammerle M, Pizzo R, Matas SLA, Novaretti T, Grassi V, Bastos V.   +32 more
europepmc   +1 more source

Efficacy and Safety of Fremanezumab in the Preventive Treatment of Migraine: A Systematic Review of Randomized Clinical Trials [PDF]

Context: Migraine is a highly prevalent and disabling neurological condition, affecting approximately one billion people worldwide. It is the second most common type of primary headache.
Gonçalves Horta, Wagner, Carvalho Figuerêdo, Nathália, Cahú Da Silva Falcão, Larissa, Gomes Fonseca, Leticia, Rafaella Uchôa Espíndola, Norma   +4 more
core